Drug Side Effects
Search
ACUTE GRAFT VERSUS HOST DISEASE ORAL
ACUTE GRAFT VERSUS HOST DISEASE ORAL
was reported 31 times
ACUTE GRAFT VERSUS HOST DISEASE ORAL is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Cytomegalovirus DNA Terminase Complex Inhibitor [EPC]
2
0.0006
1
Tetracycline-class Antibacterial [EPC]
3
0.0004
2
Asparagine-specific Enzyme [EPC]
2
0.0001
3
Calcineurin Inhibitor Immunosuppressant [EPC]
14
0.0001
4
Iron Chelator [EPC]
3
0.0001
5
Oxazolidinone Antibacterial [EPC]
3
0.0001
6
Penem Antibacterial [EPC]
3
0.0001
7
Lipid-based Polyene Antifungal [EPC]
1
0.0001
8
CD52-directed Cytolytic Antibody [EPC]
1
0.0001
9
Alkylating Drug [EPC]
11
0.0000
10
BCL-2 Inhibitor [EPC]
2
0.0000
11
Dihydrofolate Reductase Inhibitor Antibacterial [EPC]
3
0.0000
12
Janus Kinase Inhibitor [EPC]
5
0.0000
13
Topoisomerase Inhibitor [EPC]
2
0.0000
14
Polyene Antifungal [EPC]
1
0.0000
15
Folate Analog Metabolic Inhibitor [EPC]
9
0.0000
16
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
2
0.0000
17
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
2
0.0000
18
Kinase Inhibitor [EPC]
9
0.0000
19
Fluoroquinolone Antibacterial [EPC]
2
0.0000
20
Nitroimidazole Antimicrobial [EPC]
1
0.0000
21
Nucleoside Metabolic Inhibitor [EPC]
4
0.0000
22
Purine Antimetabolite [EPC]
1
0.0000
23
CD20-directed Cytolytic Antibody [EPC]
3
0.0000
24
Corticosteroid [EPC]
12
0.0000
25
Azole Antifungal [EPC]
1
0.0000
26
Proton Pump Inhibitor [EPC]
3
0.0000